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INTRODUCTION: Although mesenchymal 
stem cells (MSCs) isolation from a number of 
tissue sources have been described, very few 
literatures have reported successful isolation of 
adult MSCs from peripheral blood or its 
chondrogenic differentiation for clinical 
applications. The objective of this study is to 
isolate MSCs derived from both human bone 
marrow and peripheral blood and to compare 
their potential to undergo chondrogenesis. 
METHODS: Bone marrow (BM) and 
peripheral blood (PB) samples were collected 
into blood collection tubes containing lithium 
heparin (2-4mls). Mononuclear cells were 
separated from both types of samples using 
Ficoll–Paque PLUS by centrifugation and 
suspended in cell culture medium before being 
plated onto tissue culture flasks. Suspended 
cells were subsequently removed after 5 days of 
culture, and adherent cells were left to grow. 
Cells were sub-cultured (2–5 passages) prior to 
further cellular analyses and differentiation 
experiments. Chondrogenic pellets were 
harvested after 4-5 weeks in culture. To assess 
chondrogenesis, alcian blue and safranin-O 
were used to determine whether cartilage matrix 
proteoglycan was expressed. Chondrogenesis 
was also quantified by the amount of sulphated 
glycosaminoglycan (S-GAG) production 
measured using 1,9-dimethylmethylene blue 
(DMMB) assay.  
RESULTS: Based on our results, we were able 
to establish techniques for isolation of MSCs 
from BM and PB. The presence of surface 
marker proteins CD44, CD105, CD166 and the 
absence of CD34 in these cells (confirmed 
using flow-cytometry) indicate the high 
likelihood of successful mesenchymal stem cell 
isolation.  Histological examination revealed 
significant cellular expressions of 
proteoglycans and glycosaminoglycans 
indicating successful induction of 
chondrogenesis in our isolated MSCs.  
Fig1. Human blood derived-MSCs: the 
predominant cells consist of fibroblast-like 
cells. 
Table1. Flow cytometry analysis: Immune 
phenotype of culture-expanded MSCs.. 
DISCUSSION & CONCLUSIONS: In vitro 
induction of chondrogenesis has been 
demonstrated in both bone marrow and 
peripheral blood-derived MSCs using 3-
dimensional scaffold producing comparable 
cellular expressions. MSCs which are easily 
isolated (and less painfully harvested) from 
peripheral blood as compared to bone marrow 
provides a superior alternative source for MSCs 
for future clinical application (in this case for 
cartilage repair).   
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Antigen CD number Expression 
HCAM-1 CD44 Positive 
Endoglin CD105 Positive 
SB10/ALCAM CD166 Positive 
HCAM-1 CD34 Negative 
